Hält derzeit eine Position bei Syros Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chief Medical Officer | Syros Pharmaceuticals Inc | 1. Dezember 2015 - |
Chief Medical Officer | Infinity Pharmaceuticals Inc | 4. Februar 2014 - 11. September 2015 |
Senior Vice President - Clinical Development and Medical Affairs | Infinity Pharmaceuticals Inc | 4. September 2013 - 4. Februar 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-04-05 | 2024-04-03 |
Syros Pharmaceuticals Inc
(SYRS)
|
GV Geplanter Verkauf |
10.451
-100.0%
4,9551.732 USD |
10.451 -100.0% | 4,95 | 51.732 USD | |
2024-04-02 | 2024-04-02 |
Syros Pharmaceuticals Inc
(SYRS)
|
GV Geplanter Verkauf |
150
-1.4%
4,98747 USD |
150 -1.4% | 4,98 | 747 USD | |
2023-12-14 | 2023-12-12 |
Syros Pharmaceuticals Inc
(SYRS)
|
GV Geplanter Verkauf |
6.287
-100.0%
4,9531.121 USD |
6.287 -100.0% | 4,95 | 31.121 USD | |
2023-12-08 | 2023-12-06 |
Syros Pharmaceuticals Inc
(SYRS)
|
GV Geplanter Verkauf |
6.287
-50.0%
3,9524.834 USD |
6.287 -50.0% | 3,95 | 24.834 USD | |
2023-08-02 | 2023-07-31 |
Syros Pharmaceuticals Inc
(SYRS)
|
GV Geplanter Verkauf |
7.348
-100.0%
3,9529.025 USD |
7.348 -100.0% | 3,95 | 29.025 USD |